- Type / Class
- Equity / Common Stock
- Shares outstanding
- 20,788,527
- Total 13F shares
- 154,603,092
- Share change
- +157,862
- Total reported value
- $9,233,952,173
- Put/Call ratio
- 15%
- Price per share
- $59.72
- Number of holders
- 261
- Value change
- +$80,601,155
- Number of buys
- 138
- Number of sells
- 115
Quarterly Holders Quick Answers
What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640268108:
Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
119%
|
24,772,230
|
$594,534,000 | — | 30 Sep 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
111%
|
23,142,222
|
$555,413,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
101%
|
21,000,119
|
$504,003,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
69%
|
14,303,480
|
$343,284,000 | — | 30 Sep 2017 | |
| Camber Capital Management LP |
13F
|
Company |
25%
|
5,200,000
|
$124,800,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
19%
|
3,968,428
|
$95,246,000 | — | 30 Sep 2017 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
17%
|
3,632,419
|
$87,178,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
17%
|
3,612,747
|
$86,706,000 | — | 30 Sep 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
16%
|
3,329,281
|
$79,903,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
13%
|
2,713,717
|
$65,129,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
11%
|
2,324,346
|
$55,040,000 | — | 30 Sep 2017 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
11%
|
2,274,661
|
$54,592,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
9.9%
|
2,062,186
|
$49,493,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
9.2%
|
1,919,412
|
$46,066,000 | — | 30 Sep 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
8%
|
1,656,210
|
$39,749,000 | — | 30 Sep 2017 | |
| PointState Capital LP |
13F
|
Company |
7.6%
|
1,580,300
|
$37,927,000 | — | 30 Sep 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
7%
|
1,458,007
|
$34,992,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.9%
|
1,432,013
|
$34,368,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
6.1%
|
1,265,295
|
$30,365,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
6%
|
1,250,000
|
$30,000,000 | — | 30 Sep 2017 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
6%
|
1,237,309
|
$29,695,000 | — | 30 Sep 2017 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
5.7%
|
1,182,422
|
$28,378,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.7%
|
1,177,005
|
$28,248,000 | — | 30 Sep 2017 | |
| Duquesne Family Office LLC |
13F
|
Company |
5.6%
|
1,166,100
|
$27,986,000 | — | 30 Sep 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
4.9%
|
1,028,200
|
$24,677,000 | — | 30 Sep 2017 | |
| Rubric Capital Management LP |
13F
|
Company |
4.8%
|
996,835
|
$23,924,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.6%
|
949,025
|
$22,776,000 | — | 30 Sep 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
4.5%
|
944,883
|
$22,677,000 | — | 30 Sep 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
4.2%
|
866,194
|
$20,789,000 | — | 30 Sep 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
4%
|
833,747
|
$20,010,000 | — | 30 Sep 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
3.8%
|
792,782
|
$19,027,000 | — | 30 Sep 2017 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
3.6%
|
745,979
|
$17,903,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.4%
|
703,282
|
$16,879,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
3.4%
|
703,044
|
$16,873,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
3.2%
|
674,346
|
$16,184,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2.7%
|
553,989
|
$13,296,000 | — | 30 Sep 2017 | |
| Tamarack Advisers, LP |
13F
|
Company |
2.6%
|
550,000
|
$13,200,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.6%
|
545,687
|
$13,096,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
2.5%
|
525,453
|
$12,611,000 | — | 30 Sep 2017 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.4%
|
503,193
|
$12,077,000 | — | 30 Sep 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
2.3%
|
483,800
|
$11,611,000 | — | 30 Sep 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.2%
|
458,997
|
$11,016,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2%
|
413,245
|
$9,918,000 | — | 30 Sep 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
2%
|
412,946
|
$9,910,704 | — | 30 Sep 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
1.8%
|
378,711
|
$9,089,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.8%
|
366,506
|
$8,796,000 | — | 30 Sep 2017 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
364,756
|
$8,754,000 | — | 30 Sep 2017 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.7%
|
351,645
|
$8,439,000 | — | 30 Sep 2017 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
1.5%
|
317,292
|
$7,615,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
1.5%
|
306,478
|
$7,348,000 | — | 30 Sep 2017 |
Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q4 2017
As of 31 Dec 2017,
Nektar Therapeutics - Common Stock (NKTR) was held by
261 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
154,603,092 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., Vanguard Group Inc, OppenheimerFunds, Inc., FMR LLC, STATE STREET CORP, PointState Capital LP, JANUS HENDERSON GROUP PLC, Camber Capital Management LLC, and NORGES BANK.
This page lists
261
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
203
Q4 2017 holders
261
Holder diff
58
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.